| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 12/24/2003 | WO2003106504A1 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation |
| 12/24/2003 | WO2003106499A1 Antibody and inhibitor and transformation method and transformation kit using the same |
| 12/24/2003 | WO2003106498A2 Agonistic binding molecules to the human ox40 receptor |
| 12/24/2003 | WO2003106496A1 Antibodies, peptides and vaccines against hiv-1 virus |
| 12/24/2003 | WO2003106483A1 A recombinant anti-enveloped virus peptide and its preparation |
| 12/24/2003 | WO2003106479A2 Pokeweed antiviral protein polypeptides with antiviral activity |
| 12/24/2003 | WO2003106473A1 1-carboxymethyl analogues of glucosyl lipid a |
| 12/24/2003 | WO2003106456A2 New compounds |
| 12/24/2003 | WO2003106455A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators |
| 12/24/2003 | WO2003106446A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use |
| 12/24/2003 | WO2003106445A1 Compounds and methods for controlling bacterial virulence |
| 12/24/2003 | WO2003106433A1 Deoxyhypusine-synthase inhibitors, pharmaceuticals comprising said inhibitors and uses thereof |
| 12/24/2003 | WO2003106431A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 12/24/2003 | WO2003106425A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 12/24/2003 | WO2003106413A2 Process for the preparation of oxazolidinones and method of use thereof |
| 12/24/2003 | WO2003106385A2 Process for screening fungitoxic compounds |
| 12/24/2003 | WO2003105903A1 Antifungal medicinal composition |
| 12/24/2003 | WO2003105895A1 Vaccination with immuno-isolated cells producing an immunomodulator |
| 12/24/2003 | WO2003105893A2 Probiotic therapies |
| 12/24/2003 | WO2003105890A2 Vaccine composition |
| 12/24/2003 | WO2003105885A1 Novel method of screening |
| 12/24/2003 | WO2003105883A1 Treatment of serious infections and septic shock |
| 12/24/2003 | WO2003105878A1 Antibacterial agent and antibacterial composition |
| 12/24/2003 | WO2003105874A1 Thymic epithelial cells with progenitor capacity |
| 12/24/2003 | WO2003105872A1 Anti-spasmodic comprising xenon |
| 12/24/2003 | WO2003105870A1 Verotoxin production inhibitor |
| 12/24/2003 | WO2003105867A1 Quaternised ammonium cyclodextrin compounds |
| 12/24/2003 | WO2003105863A1 Aryl phosphate derivatives with selective activity against adenovirus and hiv |
| 12/24/2003 | WO2003105851A1 Novel crystalline forms of gatifloxacin |
| 12/24/2003 | WO2003105841A1 Antifungal medicinal compositions |
| 12/24/2003 | WO2003105816A1 Method of treating rosacea by topical application of a cyclohexane derivative |
| 12/24/2003 | WO2003105812A1 Gastroretentive drug delivery system comprising an extruded hydratable polymer |
| 12/24/2003 | WO2003105775A2 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 12/24/2003 | WO2003105771A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 12/24/2003 | WO2003105770A2 Carbocyclic nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 12/24/2003 | WO2003105769A2 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases |
| 12/24/2003 | WO2003105767A2 Antifungal parenteral products |
| 12/24/2003 | WO2003105578A1 Model animals non-responsive to mycobacteria-origin lipoprotein/lipopeptide |
| 12/24/2003 | WO2003095455A3 Substituted pyrazolopyrimidines |
| 12/24/2003 | WO2003091232A3 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 12/24/2003 | WO2003089593A3 Adjuvant enhanced immunotherapy |
| 12/24/2003 | WO2003087298A3 Nucleosides preparation thereof and use as inhibitors of rna viral polymerases |
| 12/24/2003 | WO2003086396A9 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative |
| 12/24/2003 | WO2003084940B1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
| 12/24/2003 | WO2003084462A3 Process for preparation of pharmaceutical composition containing antiretroviral protease inhibitor with improved bioavailability |
| 12/24/2003 | WO2003078455A3 Virus like particle from papillomavirus and their use in vaccine |
| 12/24/2003 | WO2003077942A3 Virus-like particles of human papillomavirus |
| 12/24/2003 | WO2003075824A3 Process of manufacturing pharmaceutical composition useful for management of tuberculosis |
| 12/24/2003 | WO2003075015A3 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 12/24/2003 | WO2003073097A9 Methods for isolating ligands e.g. t cell epitopes |
| 12/24/2003 | WO2003070914A3 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/24/2003 | WO2003070180A3 Compositions and methods for delivery of skin cosmeceuticals |
| 12/24/2003 | WO2003066845A3 Bacteriophage lysin |
| 12/24/2003 | WO2003066806A3 Therapeutic use of aziridino compounds |
| 12/24/2003 | WO2003066094A3 Hepatitis b vaccines |
| 12/24/2003 | WO2003064473A3 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity |
| 12/24/2003 | WO2003064394A8 5-ring heterocycles used as antiviral agents |
| 12/24/2003 | WO2003062236A8 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES |
| 12/24/2003 | WO2003055896A3 Anti-viral 7-deaza l-nucleosides |
| 12/24/2003 | WO2003051299A3 Sulfhydryl rifamycins and uses thereof |
| 12/24/2003 | WO2003035137A3 Method and apparatus for dispensing inhalator medicament |
| 12/24/2003 | WO2003028701A3 Liposomes containing (ether)lysolecithins |
| 12/24/2003 | WO2003014078A3 Muc7d1 peptides as antifungal and antibacterial agents |
| 12/24/2003 | WO2003007985A3 Capsular polysaccharide solubilisation and combination vaccines |
| 12/24/2003 | WO2002102997A3 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 12/24/2003 | WO2002102825A3 Fluorescently labelled locked nucleic acids |
| 12/24/2003 | WO2002096929A3 Polypeptides reacting with hcv-infected patients' antibodies and uses |
| 12/24/2003 | WO2002096455A3 Use of polyclonal immunoglobulins |
| 12/24/2003 | WO2002066037A8 Antiviral method of use |
| 12/24/2003 | WO2002060483A3 Perylenequinones for use as photosensitizers and sonosensitizers |
| 12/24/2003 | WO2002058692A3 Halogenated composition, method for preparing same and uses thereof |
| 12/24/2003 | WO2002046147A3 Perturbed membrane-binding compounds |
| 12/24/2003 | WO2002028829A3 Peptide deformylase inhibitors |
| 12/24/2003 | CN2593786Y Nano medicines against AIDS and hepatitis B |
| 12/24/2003 | CN1463177A Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds |
| 12/24/2003 | CN1462804A Filtering out non essential segment in copying adenovirus of birds, and its gene engineering products |
| 12/24/2003 | CN1462754A Medicinal complex dibaicalin zinc and its preparation method |
| 12/24/2003 | CN1462751A Method for preparing crystalline cefathiamidine and its usage |
| 12/24/2003 | CN1462636A Vaccine of recombined albumen for preventing and treating infection of human C type hepatitis virus and its usage |
| 12/24/2003 | CN1462632A Usage of internal use and external used medicine made from fleur-de-lis and its preparation method |
| 12/24/2003 | CN1462627A Chinese herbal medicine prescription for prevention and treatment of atypical pneumonia |
| 12/24/2003 | CN1462619A Medicine use of cooperation substance of zinc glycoside of baikal skullcap root |
| 12/24/2003 | CN1462618A Fibrauretine in dosage form of decentralization tablet |
| 12/24/2003 | CN1462584A Externally-used disinfector |
| 12/24/2003 | CN1131712C Colostrinin and use thereof |
| 12/24/2003 | CA2491846A1 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof |
| 12/24/2003 | CA2489870A1 Low molecular weight oversulfated polysaccharide |
| 12/24/2003 | CA2489866A1 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 12/24/2003 | CA2489854A1 Antifungal medicinal compositions |
| 12/24/2003 | CA2489645A1 Pokeweed antiviral protein polypeptides with antiviral activity |
| 12/24/2003 | CA2489447A1 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 12/24/2003 | CA2489377A1 Novel crystalline forms of gatifloxacin |
| 12/24/2003 | CA2489357A1 Aryl phosphate derivatives with selective activity against adenovirus and hiv |
| 12/24/2003 | CA2489316A1 Antibody and inhibitor, and transfection method or kit using them |
| 12/24/2003 | CA2489252A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use |
| 12/24/2003 | CA2489244A1 Treatment of serious infections and septic shock |
| 12/24/2003 | CA2489004A1 Agonistic binding molecules to the human ox40 receptor |
| 12/24/2003 | CA2488872A1 Antifungal parenteral products |
| 12/24/2003 | CA2488842A1 Carbocyclic nucleoside analogs as rna-antivirals |
| 12/24/2003 | CA2488782A1 Vaccine comprising mixtures of multivalent meningococcal outer membrane vesciles |